These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

725 related items for PubMed ID: 16029293

  • 1. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy.
    Ay E, Kavak ZN, Elter K, Gokaslan H, Pekin T.
    Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):283-8. PubMed ID: 16029293
    [Abstract] [Full Text] [Related]

  • 2. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.
    Spencer K, Yu CK, Savvidou M, Papageorghiou AT, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):658-63. PubMed ID: 16493628
    [Abstract] [Full Text] [Related]

  • 3. The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia.
    Florio P, Reis FM, Pezzani I, Luisi S, Severi FM, Petraglia F.
    Ultrasound Obstet Gynecol; 2003 Feb; 21(2):165-9. PubMed ID: 12601840
    [Abstract] [Full Text] [Related]

  • 4. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
    Davidson EJ, Riley SC, Roberts SA, Shearing CH, Groome NP, Martin CW.
    BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
    [Abstract] [Full Text] [Related]

  • 5. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
    Spencer K, Cowans NJ, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
    [Abstract] [Full Text] [Related]

  • 6. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia.
    Yu J, Shixia CZ, Wu Y, Duan T.
    Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451
    [Abstract] [Full Text] [Related]

  • 7. Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler.
    Aquilina J, Thompson O, Thilaganathan B, Harrington K.
    Ultrasound Obstet Gynecol; 2001 Jun; 17(6):477-84. PubMed ID: 11422967
    [Abstract] [Full Text] [Related]

  • 8. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A, Wilson RD, SOCIETY OF OBSTETRICIANS AND GYNAECOLOGISTS OF CANADA GENETICS COMMITTEE.
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [Abstract] [Full Text] [Related]

  • 9. Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry.
    Madazli R, Kuseyrioglu B, Uzun H, Uludag S, Ocak V.
    Int J Gynaecol Obstet; 2005 Jun; 89(3):251-7. PubMed ID: 15919391
    [Abstract] [Full Text] [Related]

  • 10. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry.
    Audibert F, Benchimol Y, Benattar C, Champagne C, Frydman R.
    Fetal Diagn Ther; 2005 Jun; 20(1):48-53. PubMed ID: 15608460
    [Abstract] [Full Text] [Related]

  • 11. Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia.
    Spencer K, Cowans NJ, Chefetz I, Tal J, Kuhnreich I, Meiri H.
    Prenat Diagn; 2007 Mar; 27(3):258-63. PubMed ID: 17278173
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Multiple marker second trimester serum screening for pre-eclampsia.
    Wald NJ, Morris JK.
    J Med Screen; 2001 Mar; 8(2):65-8. PubMed ID: 11480445
    [Abstract] [Full Text] [Related]

  • 14. Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrophin for the prediction of pre-eclampsia.
    Aquilina J, Maplethorpe R, Ellis P, Harrington K.
    Placenta; 2000 Mar; 21(5-6):487-92. PubMed ID: 10940198
    [Abstract] [Full Text] [Related]

  • 15. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels.
    Räty R, Koskinen P, Alanen A, Irjala K, Matinlauri I, Ekblad U.
    Prenat Diagn; 1999 Feb; 19(2):122-7. PubMed ID: 10215068
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Uterine vein and maternal urinary levels of activin A and inhibin A in pre-eclampsia patients.
    Muttukrishna S, Hyett J, Paine M, Moodley J, Groome N, Rodeck C.
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):469-73. PubMed ID: 16584522
    [Abstract] [Full Text] [Related]

  • 18. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.
    Wald NJ, Morris JK, Ibison J, Wu T, George LM.
    Prenat Diagn; 2006 Jun; 26(6):559-64. PubMed ID: 16700087
    [Abstract] [Full Text] [Related]

  • 19. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia.
    Spencer K, Cowans NJ, Chefetz I, Tal J, Meiri H.
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):128-34. PubMed ID: 17149788
    [Abstract] [Full Text] [Related]

  • 20. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels.
    Konchak PS, Bernstein IM, Capeless EL.
    Am J Obstet Gynecol; 1995 Oct; 173(4):1115-9. PubMed ID: 7485303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.